The MIF pathway, in particular, has been implicated in tumor inflammation and immune evasion, and its activation in NOP10+/NHP2+ PTCs may facilitate cross-talk with macrophages and T cells, contributing to an immunosuppressive niche in the ccRCC TME [49, 50]. Here, NHP2 is linked to nonpapillary renal cell carcinoma.